The company's balance sheet reveals a deficiency surpassing ...

The company's balance sheet reveals a deficiency surpassing its CN¥3.89b market cap, potentially leading to heavy dilution if liabilities are paid down by raising capital at current share price. Negative EBIT and significant liabilities make it a risky investment.